4//SEC Filing
Klausner Richard 4
Accession 0001209191-23-046267
CIK 0001806952other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:23 PM ET
Size
6.3 KB
Accession
0001209191-23-046267
Insider Transaction Report
Form 4
Klausner Richard
Director
Transactions
- Sale
Common Stock
2023-08-15$2.28/sh−58,020$132,286→ 930,880 total(indirect: Grantor)
Holdings
- 2,967,834
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.275 to $2.285, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]Consists of 245,515 shares held by The Ariella Klausner Delaware Trust, 194,335 shares held by The Eli Klausner Delaware Trust, 245,515 shares held by The Isaac Klausner Delaware Trust, and 245,515 shares held by The Olivia Klausner Delaware Trust. The Reporting Person is a grantor of each of the trusts and disclaims beneficial ownership of all shares held by the trusts except to any pecuniary interest therein. Raymond James Trust Services of Delaware is the trustee of each of the trusts.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001591178
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:23 PM ET
- Size
- 6.3 KB